Urinary Bladder, Overactive: all 864 studies
Page 5 of 9. Open to participants first (125), then studies with results posted, then the rest; newest registration first within each.
- AURA-2: Augmenting Urinary Reflex ActivityCompletedNCT05241379Not applicable
- Beta 3 Agonists in Treatment of Non-neurogenic Voiding Dysfunction in ChildrenStatus unknownNCT05240456Phase 1/2
- Open Label Study to Evaluate the Efficacy of the Home Based Electrical Transcutaneous URIS I in the Treatment of Overactive Bladder (OAB).CompletedNCT05211193
- Sequencing and Combination of Mirabegron and TTNS in Overactive Bladder Syndrome: a Multicenter, Randomized, Open-label, Crossover TrialStatus unknownNCT05188742Phase 4
- Evaluating a Digital Intervention for Overactive BladderCompletedNCT05170100Not applicable
- Evaluation of the TheraNova Neuromodulation System to Provide Durable Relief of Overactive Bladder SymptomsCompletedNCT05162833Not applicable
- Comparing Number of Injection Sites of In-office Intravesical Onabotulinumtoxin A Treatments for Overactive Bladder: A Randomized Controlled TrialStatus unknownNCT05157295Phase 4
- Overactive Bladder SyndromeCompletedNCT05151081
- Overactive Bladder Telemedicine Non-inferiority TrialCompletedNCT05117918Not applicable
- Effect of Medical Cannabis for Non-motor Symptoms of Parkinson's DiseaseStatus unknownNCT05106504
- Repetitive Transcranial Magnetic Stimulation in Women With Overactive Bladder With Urgency IncontinenceStatus unknownNCT05099419Early Phase 1
- Using Oral Valacyclovir to Treat Patients With Refractory IC/BPSStatus unknownNCT05094414Phase 1
- Stress and Anxiety Effects on Overactive BladderTerminatedNCT05087810
- Effect of Ureteral Stents Length and Location on Related SymptomCompletedNCT05069376Not applicable
- Composur: Study to Understand the Performance of Vibegron in Participants with Overactive Bladder (OAB)CompletedNCT05067478
- Predictors Affecting Long-term Use of Solifenacin or Mirabegron in Women With Overactive Bladder SyndromeStatus unknownNCT05040984
- Red Clover Isoflavones in Postmenopausal Women With Urge Urinary Incontinence and Overactive BladderCompletedNCT05013593Not applicable
- Evaluation of the The Neuromodulation System for the Treatment of Overactive Bladder SymptomsCompletedNCT04999657Not applicable
- Use of Repris Needle in Bladder InjectionStatus unknownNCT04982120Not applicable
- BO and DO in Women With Cystocele Before and After Cystocele RepairCompletedNCT04981054
- USI and/or DO in Women With Cystocele Before and After Cystocele RepairCompletedNCT04978714
- TEST-ON - Does iStim Reduce Urinary Urgency?CompletedNCT04957524Not applicable
- The Effects of Pelvic Floor Muscle Training in Women With Overactive BladdderStatus unknownNCT04950556Not applicable
- Transcutaneous Tibial Nerve Stimulation for Urgency Urinary IncontinenceActive, not recruitingNCT04936464Not applicable
- To Evaluate the Efficacy and Safety of JLP-2002 on Symptoms of Overactive BladderCompletedNCT04917315Phase 3
- The Safety and PK Characteristics of the Co-administration of JLP-2002 and Comparator in Healthy VolunteersCompletedNCT04914221Phase 1
- Strong Desire to Void and Balance in Older Women With Overactive BladderCompletedNCT04910555
- Beta-3 Agonist and Anti-muscarinic Agent for Sjogren's Syndrome With Overactive BladderStatus unknownNCT04909255Phase 4
- Evaluation of Implantable Tibial Neuromodulation (TITAN 1) Feasibility StudyCompletedNCT04873271Not applicable
- Impact of OAB Symptoms on Quality of Life in CroatiaStatus unknownNCT04865328
- Comparison and Evaluation of USSQ, OABSS, and the Drainage/Anti-reflux Effect Between Three Kinds of Ureteral D-J Stents in Patients Who Underwent URLStatus unknownNCT04858750Not applicable
- Treatment of Overactive Bladder With a Digital Conversational Agent: the MOTIVATION StudyStatus unknownNCT04853849
- OAB and the MicrobiomeTerminatedNCT04831801
- Botulinum Toxin a Vs Anticholinergic Treatment of Neurogenic Overactive Bladder in Patients with Multiple SclerosisTerminatedNCT04819360Phase 4
- BOTOX® at the Time of Prolapse Surgery for OABStatus unknownNCT04807920Phase 4
- AQUA: Anticholinergic Side Effects QUestionnAireCompletedNCT04791111
- Evaluation of the TheraNova Neuromodulation System for the Treatment of Overactive Bladder SymptomsCompletedNCT04758247Not applicable
- Intravaginal Electrical Stimulation With Different Treatment Frequency in Women With Idiopathic Overactive BladderCompletedNCT04734301Not applicable
- Effect of beta3-adrenoceptor Agonist on Patients With Overactive Bladder and as a Urinary BiomarkerStatus unknownNCT04693897
- Evaluation of Silodosin and Pelvic Floor Muscle Training in Men With Benign Prostatic Hyperplasia and Overactive BladderCompletedNCT04681625Not applicable
- ADRB3, ROCK2 and GEF Levels in Overactive Bladder PatientsCompletedNCT04626960
- Reliability of KHQ and ICIQ-SF in Assessing Urinary Incontinence Effects in Polish WomenCompletedNCT04619238
- BE Technologies Mobile Uroflowmetry Validation StudyCompletedNCT04599283Not applicable
- "The Effectiveness of Transvertebral Magnetic Neuromodulation in Patients With Detrusor Overactivity"Status unknownNCT04578899Not applicable
- LURN: Urinary Urgency Phenotyping ProtocolCompletedNCT04557748
- Predictors for Retreatement of OAB After DC MirabegronCompletedNCT04550702
- Clinical Study to Evaluate the Treatment Effect and Safety of BAY1817080 in Patients With Overactive Bladder (OAB)CompletedNCT04545580Phase 2
- A Pilot Study Evaluating the Usability of the Oabi Mobile ApplicationCompletedNCT04534946
- Feasibility Study of Transcutaneous Tibial Nerve Stimulation for Urinary Symptoms in People With Multiple SclerosisCompletedNCT04528784Not applicable
- Does Mirabegron Have a Positive Impact on Sexual Function in Females With Overactive BladderStatus unknownNCT04511273
- Low Dose Tadalafil for Treatment of Female OAB Syndrome: Short Term Follow up.CompletedNCT04500860Phase 1
- A Trial to Learn How a New Liquid Form of BAY1817080 is Tolerated and Taken up by the Body of Healthy Male Participants (Part A). By Labeling BAY1817080 With a Radioactive Substance (Carbon 14) Researchers Want to Learn How the Study Drug is Processed and Excreted by the Body After Dosing (Part B)CompletedNCT04487431Phase 1
- A Study to Evaluate Drug-drug Interactions Between BR9006-1 and BR9006-2 in Healthy Male Volunteers.CompletedNCT04485585Phase 1
- Efficacy of Transcutaneous Versus Percutaneous Posterior Tibial Nerve Stimulation in the Overactive Bladder.Status unknownNCT04483817Not applicable
- The Urinary Microbiome in Patients Receiving Intradetrusor Botox InjectionsCompletedNCT04479709
- BIOEQUIVALENCE STUDY IN HEALTHY PARTICIPANTS COMPARING 4 MG AND 8 MG FESOTERODINE EXTENDED-RELEASE TABLETS (TOVIAZ™), MANUFACTURED AT ZWICKAU VERSUS FREIBURGCompletedNCT04478357Phase 1
- Efficacy of Biofeedback PFMT and Medication in Women With Overactive BladderCompletedNCT04477265Not applicable
- Study on the Safety of BAY1817080 How it is Tolerated and the Way the Body Absorbs, Distributes and Gets Rid of the Study Drug Given to Participants With Moderate Renal Impairment and End Stage Renal Disease Requiring Dialysis Compared With Matched Participants With Normal Renal FunctionCompletedNCT04471337Phase 1
- Transcutaneous Tibial Nerve Stimulation: the ZIDA Device EquivalenceCompletedNCT04470765Not applicable
- Study on the Safety of BAY1817080, How it is Tolerated and the Way the Body Absorbs, Distributes and Gets Rid of the Study Drug in Participants With Impaired Liver Function or Normal Liver FunctionCompletedNCT04454424Phase 1
- Study To Assess The Bioequivalence Under Fed And Fasted Conditions Of The Fesoterodine Beads-In-Capsule SR4 And SR7 Formulations And To Estimate The Bioavailability of SR7 Beads Sprinkled On Apple Sauce Relative To The Beads-In-Capsule SR7 Formulation AdministerCompletedNCT04452838Phase 1
- PTNS vs Botox of Refractory OABTerminatedNCT04451382
- Pelvic Floor Magnetic Stimulation in Women With Idiopathic Overactive BladderCompletedNCT04450511Not applicable
- Efficacy of Li-SWT on Persistent Storage Symptoms After Transurethral Surgery for BPOCompletedNCT04437108Not applicable
- What is the Effect of Prolapse Surgery on Voiding?Status unknownNCT04429360
- Study to Gather Information on the Influence of BAY1817080 on the Electrical Activity of the Heart Recorded by an Electrocardiogram in Healthy Male and Female ParticipantsCompletedNCT04423744Phase 1
- Comparative Study Between Behavior Therapy and Behavior Therapy Plus Mirabegron in Sexually Active Men With OAB SymptomsCompletedNCT04420533Not applicable
- Intravaginal Electrical Stimulation in Idiopathic Overactive BladderCompletedNCT04389307Not applicable
- Effectiveness of EMS and TENS in Patients With Overactive BladderStatus unknownNCT04364438Not applicable
- NOGO for an Overactive BladderStatus unknownNCT04357223Phase 2
- Arabic Translation and Validation of the (Overactive Bladder Symptom Score) OABSSCompletedNCT04309890
- Treatment of the Overactive Bladder Syndrome: A Delphi StudyCompletedNCT04300400
- Study on the Safety of Drug BAY1817080 at Different Doses and the Way the Body Absorbs and Eliminates the Drug in Japanese Healthy Adult Male ParticipantsCompletedNCT04265781Phase 1
- TTNS Versus Sham Therapy for Children With iOAB (TaPaS Part I)TerminatedNCT04256876Not applicable
- Remote Access to Urinary Incontinence Treatment for Women VeteransCompletedNCT04237753Not applicable
- Comparison of Different Treatments for Overactive Bladder SyndromeCompletedNCT04197466Not applicable
- Evaluate the Safety and Efficacy of Botulax® Versus Botox® in Patient With Overactive BladderCompletedNCT04186442Phase 1
- Genital Nerve Stimulation - GNS - for Treatment of Non-neurogenic OABStatus unknownNCT04160793Not applicable
- In-office Assessment of Voiding Function Following Botox Injection for Overactive BladderCompletedNCT04155593
- Effectiveness of Microcurrents Therapy in Overactive Bladder.CompletedNCT04120545Not applicable
- Clinical Trial to Evaluate the Efficacy and Safety of MEDITOXIN® in Subject With Idiopathic Overactive BladderStatus unknownNCT04113941Phase 3
- Evaluation of Professional Practices in the Treatment of Refractory Idiopathic Overactive Bladder at the Dose of 50 Units (TOX50IUU)Status unknownNCT04075578
- Information, Motivation, Behavioral Skills Model on Urinary Incontinence and Quality of Life in MenCompletedNCT04068025Not applicable
- PTNS on Urinary and Global Quality of Life in MS PatientsCompletedNCT04063852
- The Effect of Low Intensity Extracorporeal Low Energy Shock Wave Therapy on Stress Urinary Incontinence and Overactivity BladderStatus unknownNCT04059133Not applicable
- High Intensity Focused Electromagnetic Field Device for Urinary IncontinenceCompletedNCT04031014Not applicable
- Pilot Phase for an Acute Evaluation of a Non-Implantable Electrical Continence DeviceCompletedNCT04001426Not applicable
- Pelvic Floor Muscle Training With Leva System for Urge IncontinenceTerminatedNCT03923348Not applicable
- Optimizing Overactive Bladder TreatmentCompletedNCT03904407Not applicable
- A Study on Anticholinergic Use: Attribution of Overactive Bladder (OAB) Medications to the Anticholinergic BurdenCompletedNCT03903094
- The Efficacy of Botulinum Toxin in OVERACTIVE BladderStatus unknownNCT03888001
- Vibe First In Human Study for the Assessment of Safety and Initial Performance of the Vibe Delivery System in Subjects With Idiopathic Overactive BladderCompletedNCT03874780Not applicable
- FemPulse Therapy First-in-Human ExperienceCompletedNCT03874637Not applicable
- Vaginal CO2 Laser in Postmenopausal Women With Overactive Bladder Syndrome (OAB)CompletedNCT03846895Not applicable
- The Clinical Effects of Laser Acupuncture Therapy for OAB Women.Status unknownNCT03829137Not applicable
- Higher Neural Changes Following Anticholinergic, Beta 3 Agonist, or Placebo in Patients With Overactive BladderCompletedNCT03817931Phase 4
- Effects of Kinesio Taping Application in Women With Overactive BladderStatus unknownNCT03817203Not applicable
- Age-specific Prevalence and Comparisons of UDS and Bladder Diary Between OAB-wet and -Dry WomenCompletedNCT03807024
- Reliability of Polish-Version Overactive Bladder Syndrom Scores (OABSS)CompletedNCT03801239
- FemPulse Therapy for Overactive Bladder in WomenCompletedNCT03784170Not applicable